INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026

Fractional shares will be rounded up for registered holders, while street-name holders will receive cash through their broker or nominee.

Rhea-AI Summary

INVO Fertility (NASDAQ: IVF) will implement a 1-for-4 reverse stock split effective October 30, 2026, at 12:01 a.m. Eastern Time. Every four issued and outstanding common shares will become one share. Trading on The Nasdaq Capital Market will begin on a post-split basis that morning under the unchanged symbol IVF.

Immediately after the split, approximately 1,192,841 common shares will be issued and outstanding. Authorized common shares will also be adjusted proportionately, leaving 62,500,000 authorized shares after the split takes effect.

News Explained

At the October 30, 2026 split, registered holders whose shares would leave a fraction will be rounded up, while holders through brokers or nominees will receive cash for the fractional amount, handled under the intermediary’s procedures.

Argus 15 min delay 4 alerts

-1.06% vs previous close $0.61 last price 0.6x rel. volume Open Argus

Details

Market Reaction – IVF

$0.54 – $0.63 Day Range

$1.53M Mkt Cap at Last Price

On Oct 27, the day this news came out, the latest delayed price for IVF is 1.06% below the previous close. Our momentum scanner has recorded 4 alerts for this stock so far that day. The latest delayed price is $0.61.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Reverse split ratio: 1-for-4 Effective time: 12:01 a.m. Eastern Time on October 30, 2026 Post-split shares outstanding: Approximately 1,192,841 shares +1 more

Reverse split ratio

1-for-4

Issued, outstanding and authorized common stock

Effective time

12:01 a.m. Eastern Time on October 30, 2026

Split effective before market opening

Post-split shares outstanding

Approximately 1,192,841 shares

Immediately after the split becomes effective

Authorized common shares

62,500,000 shares

After the effective time

Previous Stock split Reports

3 past events · Latest: Mar 25

Same Type 3 events

1. Mar 25

   Reverse stock split

   24h Move

   -6.2%

   Prior 1-for-5 split set approximately 1,615,419 outstanding shares and 50,000,000 authorized shares.

2. Nov 25

   Reverse stock split

   24h Move

   -20.2%

   Prior 1-for-8 split set approximately 1,891,151 outstanding shares and 6,250,000 authorized shares.

3. Jul 17

   Reverse stock split

   24h Move

   +1.1%

   Prior 1-for-3 split set approximately 928,272 outstanding shares and 1,388,888 authorized shares.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

reverse stock split, cusip, street name

3 terms

reverse stock split financial

"it will effect a 1-for-4 reverse split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

cusip technical

"the CUSIP number for the Company’s common stock will be 44984F872"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

View in glossary

street name financial

"holding shares in street name through a broker or nominee"

A "street name" is a way that stocks or other financial assets are registered under a broker's name rather than directly in an individual investor's name. This allows for easier buying, selling, and transferring of the assets, much like how a library might hold books on behalf of many readers. For investors, using a street name simplifies transactions and helps maintain privacy, but it also means the broker is the official record holder of ownership.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SARASOTA, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the establishment, acquisition and operation of fertility clinics and related businesses and technologies, announced today that it will effect a 1-for-4 reverse split of its issued and outstanding and of its authorized common stock effective as of 12:01 a.m. Eastern Time on October 30, 2026. Commencing with the opening of trading on The Nasdaq Capital Market on October 30, 2026, the Company’s common stock will trade on a post-split basis under the same trading symbol, “IVF”.

As a result of the reverse stock split, the CUSIP number for the Company’s common stock will be 44984F872. As a result of the reverse stock split, every 4 shares of issued and outstanding common stock will be exchanged for 1 share of common stock. Registered holders of record who would otherwise hold a fractional share will be rounded up to the next whole share. Beneficial holders holding shares in street name through a broker or nominee who would otherwise be entitled to receive a fractional share will receive a cash payment for such fractional interest, the amount of which will be determined and administered by the applicable broker or nominee in accordance with their standard procedures. Immediately after the reverse stock split becomes effective, the company will have approximately 1,192,841 shares of common stock issued and outstanding. In addition, a proportionate adjustment will be made to the company’s authorized shares of common stock such that the Company shall have 62,500,000 shares of authorized common stock after the effective time of the reverse stock split.

About INVO Fertility

We are a healthcare services fertility company dedicated to expanding assisted reproductive technology (“ART”) care to patients in need. Our principal commercial strategy is focused on building, acquiring and operating fertility clinics and related businesses and technologies. Our acquisition strategy focuses on U.S.-based, profitable fertility clinics. Our clinics offer a variety of fertility services, including in vitro fertilization (“IVF”) and the intravaginal culture (“IVC”) enabled by our INVOcell^®. We have four fertility clinics in the United States. We also continue to engage in the sale and distribution of our INVOcell technology solution into third-party owned and operated fertility clinics. INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. For more information, please visit www.invofertility.com.

Safe Harbor Statement

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company invokes the protections of the Private Securities Litigation Reform Act of 1995. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategies, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings at www.sec.gov. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

INVO Fertility, Inc.
Steve Shum, CEO
978-878-9505
sshum@invofertility.com

Investor Contact
Lytham Partners, LLC
Robert Blum
602-889-9700
INVO@lythampartners.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When does INVO Fertility's reverse stock split take effect, and what is the ratio?

INVO Fertility's 1-for-4 reverse stock split takes effect at 12:01 a.m. Eastern Time on October 30, 2026. Post-split trading begins on The Nasdaq Capital Market that morning under the unchanged ticker IVF.

How will INVO Fertility handle fractional shares in the reverse split?

Registered holders' fractional shares will be rounded up to the next whole share, while beneficial holders in street name will receive cash for fractional interests. The applicable broker or nominee will determine and administer that cash payment under its standard procedures.